{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:33:33Z","timestamp":1784666013964,"version":"3.55.0"},"reference-count":18,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,2,20]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> Since the advent of highly active antiretroviral therapy (HAART), the incidence of Kaposi's sarcoma (KS) among AIDS patients has declined both nationwide and in King County, Washington. We sought to compare clinical parameters of patients diagnosed with KS in the pre-HAART (1990 to 1996) and HAART (1997 to 2002) eras. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p> We used patient data abstracted from the Adult\/Adolescent Spectrum of HIV-Related Diseases study of Public Health\u2014Seattle and King County. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Patients diagnosed with KS in the HAART era (n = 40) were significantly more likely (P &lt; .05) than pre\u2013HAART-era KS patients (n = 366) to be diagnosed with alcohol problems (43% v 18%), noninjection drug use (45% v 18%), injection drug use (25% v 10%), psychosis (25% v 13%), and hypertension (13% v 2%). Although median CD4<jats:sup>+<\/jats:sup> count and HIV-1 viral load at the time of KS diagnosis were not significantly different between the two groups, significantly fewer (P &lt; .01) HAART-era KS patients developed opportunistic illnesses (OIs) during their follow-up. The risk of dying among KS patients diagnosed in the HAART era is significantly lower (P &lt; .01) than for KS patients diagnosed in the pre-HAART era (hazard ratio, 0.24). <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> Although HAART-era KS patients in King County were as likely to have a depleted CD4<jats:sup>+<\/jats:sup> cell count and high HIV-1 viral loads at the time of KS diagnosis as pre-HAART KS patients, they survived longer and fewer of them were diagnosed with other OIs. They also had an increased prevalence of substance abuse and mental illness, contributing to a dynamic and changing KS clinical profile. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2005.04.156","type":"journal-article","created":{"date-parts":[[2005,2,18]],"date-time":"2005-02-18T00:38:54Z","timestamp":1108687134000},"page":"1253-1260","source":"Crossref","is-referenced-by-count":68,"title":["Profile of Patients With Kaposi's Sarcoma in the Era of Highly Active Antiretroviral Therapy"],"prefix":"10.1200","volume":"23","author":[{"given":"James H.","family":"Gallafent","sequence":"first","affiliation":[{"name":"From the University of Washington, School of Medicine and Department of Epidemiology; Public Health\u2014Seattle and King County, HIV\/AIDS Epidemiology Program; and Virginia Mason Medical Center, Division of Hematology\/Oncology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Buskin","sequence":"additional","affiliation":[{"name":"From the University of Washington, School of Medicine and Department of Epidemiology; Public Health\u2014Seattle and King County, HIV\/AIDS Epidemiology Program; and Virginia Mason Medical Center, Division of Hematology\/Oncology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"De Turk","sequence":"additional","affiliation":[{"name":"From the University of Washington, School of Medicine and Department of Epidemiology; Public Health\u2014Seattle and King County, HIV\/AIDS Epidemiology Program; and Virginia Mason Medical Center, Division of Hematology\/Oncology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Aboulafia","sequence":"additional","affiliation":[{"name":"From the University of Washington, School of Medicine and Department of Epidemiology; Public Health\u2014Seattle and King County, HIV\/AIDS Epidemiology Program; and Virginia Mason Medical Center, Division of Hematology\/Oncology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09028-4"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200308150-00001"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607253350403"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200308150-00015"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116422"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00018"},{"key":"R7","unstructured":"Offermann MK: Consideration of host-viral interactions in the pathogenesis of Kaposi's Sarcoma. J Acquir Immune Defic Syndr 21:S58,1999-S65,"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00002"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307250-00001"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200007010-00013"},{"key":"R11","unstructured":"Jacobson LP, Yamashita TE, Detels R, et al: Impact of potent antiretroviral therapy on the incidence of Kaposi's Sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. J Acquir Immune Defic Syndr 21:S34,1999-S41,"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.22.1823"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1086\/313843"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480130114035"},{"key":"R16","unstructured":"Centers for Disease Control and Prevention: 1993 Revised Classification System for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41:1,1992-19,"},{"key":"R20","unstructured":"Ball SC: Kaposi sarcoma and its changing course in HIV infection. AIDS Reader 13:470,2003-479,"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Martin-Carbonero L, Barrios A, Saballs P, et al: Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma. AIDS 20:1737,2004-1740,","DOI":"10.1097\/01.aids.0000131385.60974.b9"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11816"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.04.156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:41:25Z","timestamp":1653511285000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.04.156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,20]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,2,20]]}},"alternative-id":["10.1200\/JCO.2005.04.156"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.04.156","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,20]]}}}